awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37866319-31366440-345E-4F69-A44C-486F82226E93
Q37866319-31366440-345E-4F69-A44C-486F82226E93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37866319-31366440-345E-4F69-A44C-486F82226E93
Ritonavir-boosted protease inhibitors in HIV therapy.
P2860
Q37866319-31366440-345E-4F69-A44C-486F82226E93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37866319-31366440-345E-4F69-A44C-486F82226E93
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
abdd6cc402cde8a97c771d432d66b31f022c893a
P2860
A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-naive subjects through 48 weeks.